Legault JT, Strittmatter L, Tardif J, et al. A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome. Cell Rep. 2015;13(5):981-9. doi:10.1016/j.celrep.2015.09.054
Kats LM, Reschke M, Taulli R, et al. Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell. 2014;14(3):329-41. doi:10.1016/j.stem.2013.12.016
Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1(1):75-87.
Skates SJ, Gillette MA, LaBaer J, et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res. 2013;12(12):5383-94. doi:10.1021/pr400132j
Klockars T, Holmberg V, Savukoski M, Lander ES, Peltonen L. Transcript identification on the CLN5 region on chromosome 13q22. Hum Genet. 1999;105(1-2):51-6.
Wolf AR, Mootha VK. Functional genomic analysis of human mitochondrial RNA processing. Cell Rep. 2014;7(3):918-31. doi:10.1016/j.celrep.2014.03.035
Cancer Target Discovery and Development Network, Schreiber SL, Shamji AF, et al. Towards patient-based cancer therapeutics. Nat Biotechnol. 2010;28(9):904-6. doi:10.1038/nbt0910-904
Sandoval GJ, Graham DB, Gmyrek GB, et al. Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL. Cancer Immunol Res. 2013;1(6):426-37. doi:10.1158/2326-6066.CIR-13-0065
Grgic I, Hofmeister AF, Genovese G, et al. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int. 2014;86(6):1116-29. doi:10.1038/ki.2014.204